Penetrating Pain Relief Jaxsens
Menthol
Cosmetic Enterprises Ltd
Human Otc Drug
NDC 56152-5006Penetrating Pain Relief Jaxsens also known as Menthol is a human otc drug labeled by 'Cosmetic Enterprises Ltd'. National Drug Code (NDC) number for Penetrating Pain Relief Jaxsens is 56152-5006. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Penetrating Pain Relief Jaxsens drug includes Menthol - 7.5 g/100g . The currest status of Penetrating Pain Relief Jaxsens drug is Active.
Drug Information:
| Drug NDC: | 56152-5006 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Penetrating Pain Relief Jaxsens |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Penetrating Pain Relief |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Jaxsens |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Menthol |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Cosmetic Enterprises Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Lotion |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | MENTHOL - 7.5 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 13 Dec, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 24 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part348 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | COSMETIC ENTERPRISES LTD
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 808937
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0858308003007
|
| UPC stands for Universal Product Code. |
| UNII: | L7T10EIP3A
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 56152-5006-1 | 113.4 g in 1 PACKAGE (56152-5006-1) | 13 Dec, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Uses for the relief of aches and pains of muscles and joints associated with arthritis, backache, strains, bruises, and cramps
Product Elements:
Penetrating pain relief jaxsens menthol menthol menthol carbomer copolymer type a (allyl pentaerythritol crosslinked) arnica montana flower indian frankincense calendula officinalis flower medium-chain triglycerides caprylyl glycol carboxypolymethylene matricaria chamomilla flowering top chondroitin sulfate (bovine) feverfew citric acid monohydrate coconut oil turmeric dimethyl isosorbide dimethyl sulfone glucosamine hydrochloride glycerin glyceryl monostearate harpagophytum procumbens root lonicera japonica top menthyl lactate, (-)- phenoxyethanol potassium sorbate sodium hydroxide comfrey leaf tocopherol urtica dioica leaf vanillyl butyl ether water xanthan gum
Indications and Usage:
Stop use and ask a doctor if rash irritation of skin develops and lasts. condition worsens or symptoms persist for more than 7 days symptoms clear up and occur again within a few days
Warnings:
Warnings: for external use only when using this product avoid contact with the eyes or mucous membranes do not bandage tightly ask a doctor before use if there is redness over affected area do not use on wounds or damaged skin with a heat pad
Dosage and Administration:
Directions â âuse only as directed apply to painful area 3 to 4 times daily gently massage the cream into skin children under 6 years of age: consult a doctor
Package Label Principal Display Panel:
Jaxsens provides penetrating pain relief patented formula for muscle and joint pain net. weight 4 oz(113.4g) image description